Snibe attained outstanding results across all 9 biochemistry routine assays and 18 concentration levels in this assessment with a 100% pass rate. This achievement further validates the accuracy of Snibe’s biochemical assays and our robust capability in metrological traceability.
Company News10-13 |
by
snibe
KAING is dedicated to researching cutting-edge medical image processing algorithms, 3D display technology, and new display technologies like Mini-LED and OLED. Our mission is to deliver technologically advanced, high-quality, and reliable products to our clients.
Company News10-12 |
by
owen
LINKS Medical Scientific (Shanghai) Co., Ltd. (LINKS CRO) is a Contract Research Organization (CRO) headquartered in Shanghai, China. We are dedicated to providing comprehensive clinical trial services, specifically designed for high-risk implantation (intervention) medical devices. Our primary foc
Company News10-12 |
by
owen
The 36th World Congress of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG 2026) was recently held in London, UK. As one of the leading international events in obstetric and gynecological ultrasound, the congress brought together more than 2,500 clinicians, experts, resea
Regarded as a technical background company, we focus R&D and manufacturing of imaging module for medical endoscope
Company News09-29 |
by
owen
Offering specialised services including medical research, pre-clinical large animal testing, clinical trials and global registration.
Company News09-29 |
by
owen
On September 9, 2026, the Center for Medical Device Evaluation (CMDE) of the National Medical Products Administration (NMPA) issued the *Public Notice on Review Results of Applications under the Special Review Procedure for Innovative Medical Devices (No.15, 2026)*, proposing to approve eight medica
Professor Song Enming, PhD Supervisor at the Institute of Optoelectronics, Fudan University and Chief Scientist of Full-Brain Core Technology (Shanghai) Co., Ltd., will attend the conference and deliver a keynote speech entitled *Implantable Silicon-Based Neuromodulation Devices and Systems*.
On September 4, Shuli Innovation (Shanghai) Intelligent Technology Co., Ltd. completed counseling filing registration with the Shanghai Securities Regulatory Bureau, officially commencing its pre‑IPO counseling for the STAR Market, with Huatai United Securities acting as the counseling institution.
On September 1, 2026, U.S. orthopedic‑device firm Enovis Corporation officially announced that it has entered into a binding acquisition offer with French orthopedic surgical‑robot company eCential Robotics.
On September 1, 2026, Medtronic, a global medical‑technology giant, and Cornerstone Robotics, a Chinese laparoscopic surgical robot developer, officially announced a deep strategic partnership.
At the Medical‑Health Pavilion of the Changping‑Future Science City exhibition group, Chunfeng Huayu (Beijing) Intelligent Medical Technology Co., Ltd. showcased its self‑developed world‑first three‑arm surgical robot. Boasting its groundbreaking human‑shaped three‑arm architecture and end‑to‑end in
On August 7, 2026, Intuitive Surgical’s gastrointestinal endoscopic robot, the IG1000, secured FDA 510(k) clearance under clearance number K253702.
Within an implantable‑BCI system, electrodes are responsible for capturing neural signals and chips execute signal‑processing computations. The hermetic feedthrough, by contrast, serves as the critical gateway for signals to pass through the sealed housing of the implanted device.
On August 27, 2026, Apollomics (688176.SH) officially announced that its independently‑developed portable single‑use flexible blue‑light cystoscope, APLD‑2304, has successfully obtained CE certification under the EU Medical Device Regulation (MDR), alongside an ISO 13485:2016 Quality Management Syst
Recently, a domestic‑developed laparoscopic surgical robot has achieved a landmark breakthrough in core‑technology dimensions.
On August 25, Lepu Medical (300003.SZ) released its investor‑relations activity record, disclosing that the company’s interventional multi‑channel brain‑computer‑interface (BCI) product has successfully completed animal experiments and officially entered the human‑subject Investigator‑Initiated Tria
According to a recent announcement on GeRay‑Tech’s official WeChat account, its Newton‑Endo series minimally‑invasive spinal endoscopic surgical robot has successfully completed the world’s first in‑vivo animal experiment with autonomous robotic operation, under the full‑process witness of the team
Recently, the U.S. Food and Drug Administration (FDA) has granted commercialization authorization for Aletta, a fully‑autonomous blood‑collection robot developed by Dutch medical‑robotics firm Vitestro, via the De Novo classification pathway for innovative medical devices.
Invasive brain‑computer interfaces represent the most promising technical pathway for high‑fidelity neuronal signal acquisition and the restoration of impaired neural functions.
On the evening of August 20, United Imaging Healthcare released its 2026 half‑year report. The company posted revenue of RMB 7.052 billion in the first half of the year, representing a 17.22% year‑on‑year increase. Its net profit attributable to parent shareholders stood at RMB 897 million, down 10.
Indian surgical‑robotics enterprise SS Innovations delivered an impressive growth performance in the first half of 2026.
DARPA is concurrently advancing two cutting‑edge technology pathways related to the brain.
Against the backdrop of the growing prevalence of minimally‑invasive diagnostic and therapeutic techniques in urology, the domestic localization of endoscopic devices has reached a critical inflection point.
Recently, the U.S. has launched a landmark collective research program on autonomous surgical robots.
On August 12, 2026, tricuspid‑valve interventional device developer Versa Vascular announced two major adjustments.
On August 10, Teledyne Technologies and Varex Imaging (hereinafter‑referred to as "Varex") jointly announced the signing of a definitive acquisition agreement.
According to recent official announcements from Gen‑pro Medical, its international expansion has reached a key milestone. The company’s multi‑port laparoscopic surgical robot has completed its first commercial installation and successfully performed the initial clinical operation at Penang Adventist
On August 10, 2026, foreign‑media reports stated that Shanghai Jieti Medical Technology Co., Ltd. is developing an intravascular‑implantable brain‑computer interface.
Philips has recently partnered with six companies to expand its capabilities in wearable devices and out‑of‑hospital patient monitoring.
